RxDoctor Payments DataLook up a doctor →

Violet Amirjalali

Physician Assistant · Las Vegas, NVNPI 1558686659

Payments from drug & device makers

$14,992in general payments, 2019–2025

Across 787 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$900
  • AstraZeneca$843
  • Bayer$811
  • Xeris Pharmaceuticals, Inc.$753
  • plus $9K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)62$1,396
Novo Nordisk82$1,321
Lilly USA, LLC57$900
AstraZeneca(2 entities)43$843
Bayer48$811
Xeris Pharmaceuticals, Inc.37$753
Dexcom, Inc.36$685
Sanofi-aventis U.S. LLC23$648
Radius Health, Inc.28$582
Abbott32$579
Boehringer Ingelheim36$545
Recordati_rare_diseases_inc.23$433
AbbVie25$400
Medtronic13$373
Tandem Diabetes Care, Inc.19$373
Mannkind Corporation21$369
IBSA Pharma Inc.18$332
Corcept Therapeutics18$307
Astellas Pharma US Inc11$273
Kyowa Kirin, Inc.9$222
BETA Bionics, Inc.6$207
Pfizer10$205
Amneal Pharmaceuticals LLC11$182
Esperion Therapeutics, Inc.9$178
Amarin Pharma, Inc.9$177
Embecta Corp.10$161
Novartis7$139
Almatica Pharma LLC6$138
Ascendis Pharma Endocrinology Inc10$137
Antares Pharma, Inc.7$119
Amryt Pharma Holdings Ltd5$110
Boston Scientific5$105
Tolmar, Inc.5$104
Amphastar Pharmaceuticals, Inc.5$94
Insulet Corporation5$85
Neurocrine Biosciences, Inc.3$83
Lifescan, Inc.3$69
Ascensia Diabetes Care US Inc.3$57
Ultragenyx Pharmaceutical Inc.3$53
BD3$50
Chiesi USA, Inc.2$46
Acella Pharmaceuticals, LLC2$33
Sequel Med Tech, LLC1$28
Soleno Therapeutics, Inc.1$28
Merck2$25
Kowa Pharmaceuticals America, Inc.1$24
GSK1$23
Lexicon Pharmaceuticals, Inc.1$21
Madrigal Pharmaceuticals1$20
Intra-sana Laboratories1$20
Alvogen Inc1$20
Averitas Pharma Inc.1$19
Biomarin Pharmaceutical Inc.1$17
Bigfoot Biomedical Inc1$17
Zealand Pharma US, Inc.1$16
Takeda Pharmaceuticals U.S.A., Inc.1$15
Halozyme Inc1$15
GRT US Holding, Inc.1$11

How this compares

$14,992 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada →

Medicare billing

Part B allowed, 2024
$20,842
Medicare patients
100
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →